Frédérick Durand

Achieving Pain Control in Rheumatoid Arthritis with Baricitinib or Adalimumab Plus Methotrexate: Results from the RA-BEAM Trial

Peter C. Taylor, Yvonne Lee, Roy Fleischmann et al. · Journal of Clinical Medicine · 2019 · 84 citations · Full text

Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study

Marc Ferrante, Geert D’Haens, Vipul Jairath et al. · The Lancet · 2024 · 76 citations

Moderately-to-severely Active Crohn, Immunology, Gastroenterology +5

Continuous Cefazolin Infusion To Treat Bone and Joint Infections: Clinical Efficacy, Feasibility, Safety, and Serum and Bone Concentrations

Valérie Zeller, Frédérick Durand, Marie-Dominique Kitzis et al. · Antimicrobial Agents and Chemotherapy · 2008 · 67 citations · Full text

Bone Disease, Joint Infection, Antimicrobial Susceptibility +15

Concomitant Use of Statins in Tocilizumab-Treated Patients with Rheumatoid Arthritis: A Post Hoc Analysis

Martin Soubrier, Jinglan Pei, Frédérick Durand et al. · Rheumatology and Therapy · 2016 · 32 citations · Full text

Ultraviolet A1 phototherapy for treatment of acrosclerosis in systemic sclerosis: controlled study with half‐side comparison analysis

Frédérick Durand, D. Staumont, A. Bonnevalle et al. · Photodermatology Photoimmunology & Photomedicine · 2007 · 31 citations